An integrated human forebrain organoid reveals microglia-mediated CD8<sup>+</sup> T cell recruitment and neuroimmune dysfunction in Alzheimer’s disease pathology
Genetic evidence implicates immune dysfunction in Alzheimer’s disease (AD), yet the neuroimmune mechanisms operating in human tissue remain poorly defined. Here, we establish a modular human forebrain organoid platform that systematically integrates human induced pluripotent stem cell-derived microglia and CD8 + T cells to reconstitute multicellular AD pathology. This system enables functional…
A groundbreaking study unveils the intricate interplay between human microglia, CD8+ T cells, and Alzheimer's disease pathology using an innovative human forebrain organoid platform. This breakthrough research, published in the journal <source c028de25-a95> </source>, sheds new light on the immune mechanisms at play in human tissue and offers a promising avenue for exploring neuroimmune interactions in Alzheimer's.
The study, conducted by a team of scientists, establishes a modular human forebrain organoid platform that integrates human induced pluripotent stem cell-derived microglia and CD8+ T cells. This cutting-edge system allows researchers to create a multicellular model that faithfully reproduces the complex Alzheimer's pathology in a human-relevant context. By utilizing this platform, scientists can now probe both innate and adaptive immune components in a manner that closely mirrors the human brain.
The findings reveal that microglia, the resident immune cells of the brain, play a dual role in Alzheimer's disease. On one hand, they are responsible for clearing amyloid-β plaques and promoting neuronal maturation. However, microglia also contribute to inflammatory activation, leading to a neuroinflammatory feedback loop. This loop recruits CD8+ T cells through a complex signaling cascade involving CCL4/5 and their respective receptors, CCR1/5 and CXCR3.
The researchers further demonstrate that pharmacological targeting of CCR5 or CXCR3 can effectively block T cell recruitment, while simultaneously modulating autophagy in a microglia-dependent manner. This discovery opens up exciting possibilities for the development of novel therapeutic strategies that specifically target the neuroimmune dysfunction observed in Alzheimer's disease.
The modular organoid platform developed by the research team offers a versatile tool for dissecting the intricate neuron-immune interactions that underlie Alzheimer's pathology. By enabling cell-type-specific therapeutic screening, this platform provides an invaluable resource for the development of targeted interventions aimed at mitigating the devastating effects of this neurodegenerative disorder.
These groundbreaking findings pave the way for a deeper understanding of the complex interplay between the immune system and Alzheimer's disease in human tissue. As the authors state, "This modular organoid platform provides a versatile tool for dissecting neuron–immune interactions and enables cell-type-specific therapeutic screening in human neuroinflammatory disease models."
The implications of this research are far-reaching, potentially revolutionizing the way we approach the diagnosis, treatment, and prevention of Alzheimer's disease.
Written by urgent.news from eLife's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
